Cellectar Biosciences, Inc. is a biotechnology company focused on developing innovative drugs for the diagnosis and treatment of cancer. Their main product is a technology based on molecular probes that enable targeted detection and treatment of cancer cells. This technology is designed to increase the sensitivity and accuracy of cancer diagnostics and allow for selective therapeutic effects on tumor cells with minimal side effects. Cellectar Biosciences, Inc. is developing various products utilizing this technology, including diagnostic probes and therapeutic drugs, which may bring new options in cancer treatment and improve patient prognosis.
Feed
There are no posts to show right now.
We use cookies to improve your experience on our site.
